GOLDMAN SACHS GROUP INC - EPIZYME INC ownership

EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EPIZYME INC
ValueSharesWeighting
Q2 2022$3,866,000
-41.5%
2,629,998
-54.2%
0.00%0.0%
Q1 2022$6,603,000
-19.1%
5,742,140
+76.0%
0.00%
-50.0%
Q4 2021$8,157,000
+178.4%
3,262,543
+470.3%
0.00%
+100.0%
Q3 2021$2,930,000
-36.2%
572,106
+3.6%
0.00%0.0%
Q2 2021$4,590,000
-26.0%
552,342
-22.4%
0.00%
-50.0%
Q1 2021$6,201,000
-8.8%
711,960
+13.7%
0.00%0.0%
Q4 2020$6,800,000
+3.6%
626,179
+13.8%
0.00%0.0%
Q3 2020$6,566,000
-38.6%
550,332
-17.4%
0.00%
-33.3%
Q2 2020$10,694,000
+44.6%
665,868
+39.6%
0.00%
+50.0%
Q1 2020$7,398,000
-37.9%
477,028
-1.5%
0.00%
-33.3%
Q4 2019$11,914,000
+108.6%
484,311
-12.5%
0.00%
+50.0%
Q3 2019$5,711,000
-3.2%
553,575
+17.8%
0.00%0.0%
Q2 2019$5,898,000
+15.6%
469,933
+14.1%
0.00%0.0%
Q1 2019$5,102,000
+398.7%
411,780
+147.9%
0.00%
Q4 2018$1,023,000
-30.2%
166,080
+20.1%
0.00%
Q3 2018$1,465,000
-4.9%
138,260
+21.6%
0.00%
Q2 2018$1,541,000
-57.0%
113,732
-43.7%
0.00%
-100.0%
Q1 2018$3,585,000
+116.2%
201,981
+52.9%
0.00%
Q4 2017$1,658,000
-77.4%
132,110
-65.7%
0.00%
-100.0%
Q3 2017$7,348,000
+199.9%
385,702
+137.7%
0.00%
Q2 2017$2,450,000
+192.0%
162,269
+231.6%
0.00%
Q1 2017$839,000
+29.9%
48,931
-8.3%
0.00%
Q4 2016$646,000
+182.1%
53,382
+128.9%
0.00%
Q3 2016$229,000
+38.8%
23,321
+45.0%
0.00%
Q2 2016$165,000
-10.3%
16,080
+5.7%
0.00%
Q1 2016$184,000
-82.5%
15,209
-81.4%
0.00%
Q3 2015$1,053,000
-79.0%
81,910
-60.9%
0.00%
-100.0%
Q2 2015$5,026,000
+2205.5%
209,413
+1704.8%
0.00%
Q1 2015$218,000
-58.2%
11,603
-58.0%
0.00%
Q4 2014$521,000
+56.9%
27,627
+125.5%
0.00%
Q3 2014$332,000
-37.8%
12,254
-28.6%
0.00%
Q2 2014$534,00017,1600.00%
Other shareholders
EPIZYME INC shareholders Q3 2020
NameSharesValueWeighting ↓
TUDOR INVESTMENT CORP ET AL 218,384$4,0000.00%
View complete list of EPIZYME INC shareholders